Steven Schultz from Momentum chose Bristol-Myers Squibb as his stock pick of the day.

“My stock pick today is a US-listed biopharm by the name of Bristol-Myers Squibb. It is a specialist in immune-oncology treatments and it’s a company that’s been around for 80 years, so an exceptionally strong balance sheet.”..

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.